logo

Indian News

Share SHARE

Pharma-082317.jpg Today's Daily Dose brings you news about InspireMD's listing deficiency; MabVax's exploration of strategic alternatives; Novogen's progress in developing GDC-008 in glioblastoma; Psychemedics' launch of Synthetic Cannabinoids test and disappointing results from Ultragenyx's GNE Myopathy trial.

Aug22-082217.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of August 22, 2017.

Trump-Afghan-troop-082217.jpg President Donald Trump's expansive new strategy for South Asia and his decision not to withdraw US forces from Afghanistan for the time being received mixed response from across the political spectrum. Unlike the recent critical approach from his own party members on his controversial remarks, Trump's...

Trump-SouthAsia-082217.jpg President Donald Trump ruled out an immediate withdrawal of U.S. forces from Afghanistan on Monday as he unveiled an expansive new strategy for South Asia aimed at bolstering America's security. In his first prime-time televised address to the nation as commander-in-chief, Trump claimed a hasty U.S....

Pharma-082217.jpg Today's Daily Dose brings you news about European approval of Alexion's Soliris for an additional indication; Alkermes' New Drug Application for a major depressive disorder drug; Astellas' MORPHO trial progress; Axovant's move to NASDAQ from the Big Board; Cardiome's disappointing update related to its antiarrhythmic drug and FDA approval of Ironwood's gout drug.

Aug21-082117.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of August 22, 2017.

DaveAndBusters-082117.jpg Shares of Dave & Buster's Entertainment Inc. (PLAY) are 18% down from their 52-week intraday high of $73.48 recorded on June 8, 2017.

Follow RTT